Loading...
Please wait, while we are loading the content...
Similar Documents
A step in the right direction ?
| Content Provider | Semantic Scholar |
|---|---|
| Author | Sébastian Trainor Ananya Choudhury Robert Huddart Anné Kiltie Roger Kockelbergh Turner, William Birtle, Alison J. Crabb, Simon J. |
| Copyright Year | 2017 |
| Abstract | Bladder cancer is the 7 commonest cancer in the UK accounting for 5,369 deaths in 2014 [1]. Over the last decade, despite improvements in other cancers, bladder cancer survival has remained static [2, 3]. Treatment of incurable metastatic disease remains challenging, with cisplatin-based combination chemotherapy providing only 14 months median survival [4]. Bladder cancer and its treatment can have a significant detrimental impact on patient quality of life and mental wellbeing [5-7], with reported patient experience and satisfaction scores worse than for other cancers [8, 9]. This may be compounded by variations in treatment utilisation throughout the UK [10]. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://repository.icr.ac.uk/bitstream/handle/internal/454/BUG%20Bladder%20Cancer%20NICE%20guideline%20session%20editorial.pdf?isAllowed=y&sequence=6 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
